Skip to main content
Log in

Association between the receptor for advanced glycation end products gene polymorphisms and coronary artery disease

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Receptor for advanced glycation end products (RAGE) is a cell-surface molecule member of the immunoglobulin superfamily and thought to play a critical role in diabetic atherosclerosis. A growing body of studies has been conducted to determine the extent to which the variants of RAGE gene influence the risk of coronary artery disease (CAD). However, these have reported conflicting results. To investigate this inconsistency, we performed a comprehensive meta-analysis on the associations between the RAGE −374T/A, −429T/C, and Gly82Ser polymorphisms and the risk of CAD. A total of 4,402 cases and 6,081 controls from 17 published case–control studies were included. The overall odds ratio (OR) of CAD was 0.99 (95 % CI 0.87–1.13), 1.06 (95 % CI 0.95–1.18) and 1.12 (95 % CI 0.90–1.39) for −374A, −429C, and the minor S allele of the Gly82Ser polymorphism, respectively. Similarly, no significant results were observed for these polymorphisms using dominant model. However, when stratified by diabetic/non-diabetic status of the CAD patients, we found significant association among Caucasian type two diabetic CAD patients with the −374A allele [OR 1.39, 95 % CI 1.10–1.76, P(Z) = 0.006], while no association was detected between the −374T/A polymorphism and non-diabetic CAD in Caucasians [OR 0.79, 95 % CI 0.58–1.07, P(Z) = 0.13]. In conclusion, this meta-analysis suggested that possession of the −374A allele may be a risk factor in CAD among Caucasian patients with type two diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Novelli G, Borgiani P, Giardina E, Mango R, Contino G, Romeo F, Mehta JL (2003) Role of genetics in prevention of coronary atherosclerosis. Curr Opin Cardiol 18(5):368–371

    Article  PubMed  Google Scholar 

  2. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423):801–809

    Article  PubMed  CAS  Google Scholar 

  3. Scheuner MT (2003) Genetic evaluation for coronary artery disease. Genet Med 5(4):269–285

    Article  PubMed  Google Scholar 

  4. Muendlein A, Saely CH, Rhomberg S, Sonderegger G, Loacker S, Rein P, Beer S, Vonbank A, Winder T, Drexel H (2009) Evaluation of the association of genetic variants on the chromosomal loci 9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery disease. Atherosclerosis 205(1):174–180

    Article  PubMed  CAS  Google Scholar 

  5. Lin L, Park S, Lakatta EG (2009) RAGE signaling in inflammation and arterial aging. Front Biosci 14:1403–1413

    Article  CAS  Google Scholar 

  6. Basta G (2008) Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 196(1):9–21

    Article  PubMed  CAS  Google Scholar 

  7. Yan SF, Ramasamy R, Naka Y, Schmidt AM (2003) Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93(12):1159–1169

    Article  PubMed  CAS  Google Scholar 

  8. Li J, Schmidt AM (1997) Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272(26):16498–16506

    Article  PubMed  CAS  Google Scholar 

  9. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37(3):586–600

    Article  PubMed  CAS  Google Scholar 

  10. Bucciarelli LG, Wendt T, Rong L, Lalla E, Hofmann MA, Goova MT, Taguchi A, Yan SF, Yan SD, Stern DM, Schmidt AM (2002) RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 59(7):1117–1128

    Article  PubMed  CAS  Google Scholar 

  11. Hudson BI, Wendt T, Bucciarelli LG, Rong LL, Naka Y, Yan SF, Schmidt AM (2005) Diabetic vascular disease: it’s all the RAGE. Antioxid Redox Signal 7(11–12):1588–1600

    Article  PubMed  CAS  Google Scholar 

  12. Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44(2):129–146

    Article  PubMed  CAS  Google Scholar 

  13. Wendt T, Bucciarelli L, Qu W, Lu Y, Yan SF, Stern DM, Schmidt AM (2002) Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep 4(3):228–237

    Article  PubMed  Google Scholar 

  14. Simm A, Casselmann C, Schubert A, Hofmann S, Reimann A, Silber RE (2004) Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction. Exp Gerontol 39(3):407–413

    Article  PubMed  CAS  Google Scholar 

  15. Wautier JL, Schmidt AM (2004) Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95(3):233–238

    Article  PubMed  CAS  Google Scholar 

  16. Hudson BI, Stickland MH, Grant PJ (1998) Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 47(7):1155–1157

    Article  PubMed  CAS  Google Scholar 

  17. Hudson BI, Stickland MH, Futers TS, Grant PJ (2001) Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50(6):1505–1511

    Article  PubMed  CAS  Google Scholar 

  18. Laki J, Kiszel P, Vatay A, Blasko B, Kovacs M, Korner A, Madacsy L, Blatniczky L, Almassy Z, Szalai C, Rajczy K, Pozsonyi E, Karadi I, Fazakas A, Hosszufalusi N, Panczel P, Arason GJ, Wu YL, Zhou B, Yang Y, Yu CY, Fust G (2007) The HLA 8.1 ancestral haplotype is strongly linked to the C allele of −429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the −429C allele with high hemoglobinA1C levels in diabetic patients. Mol Immunol 44(4):648–655

    Article  PubMed  CAS  Google Scholar 

  19. Falcone C, Campo I, Emanuele E, Buzzi MP, Geroldi D, Belvito C, Zorzetto M, Sbarsi I, Cuccia M (2005) 374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Clin Chim Acta 354(1–2):111–116

    Article  PubMed  CAS  Google Scholar 

  20. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, Lalla E, Chitnis S, Monteiro J, Stickland MH, Bucciarelli LG, Moser B, Moxley G, Itescu S, Grant PJ, Gregersen PK, Stern DM, Schmidt AM (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3(3):123–135

    Article  PubMed  CAS  Google Scholar 

  21. Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH (2007) Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56(2):199–205

    Article  PubMed  CAS  Google Scholar 

  22. DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28(2):105–114

    Article  PubMed  Google Scholar 

  23. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748

    PubMed  CAS  Google Scholar 

  24. Kirbis J, Milutinovic A, Steblovnik K, Teran N, Terzic R, Zorc M (2004) The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Coll Antropol 28(2):611–616

    PubMed  CAS  Google Scholar 

  25. Gao J, Shao Y, Lai W, Ren H, Xu D (2010) Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population. J Hum Genet 55(10):668–675

    Article  PubMed  CAS  Google Scholar 

  26. Aydogan HY, Kucukhuseyin O, Tekeli A, Isbir T (2012) Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients. Genet Test Mol Biomarkers 16(2):134–137

    Article  PubMed  CAS  Google Scholar 

  27. Boiocchi C, Bozzini S, Buzzi MP, Schirinzi S, Zorzetto M, Pelissero G, Cuccia M, Falcone C (2011) Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated? Rejuvenation Res 14(1):67–73

    Article  PubMed  CAS  Google Scholar 

  28. Falcone C, Campo I, Emanuele E, Buzzi MP, Zorzetto M, Sbarsi I, Cuccia M (2004) Relationship between the −374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int J Mol Med 14(6):1061–1064

    PubMed  CAS  Google Scholar 

  29. Hofmann MA, Yang Q, Harja E, Kedia P, Gregersen PK, Cupples LA, Schmidt AM, Hudson BI (2005) The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study. Atherosclerosis 182(2):301–305

    Article  PubMed  CAS  Google Scholar 

  30. Hou X (2011) The study of the relationship between single nucleotide polymorphism of receptor for advanced glycation end products and coronary angiography in a positive. Prev Treat Cardio-Cereb-Vasc Dis 11(4):272–274

    Google Scholar 

  31. Kucukhuseyin O, Aydogan HY, Isbir CS, Isbir T (2009) Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease. In Vivo 23(6):949–954

    PubMed  CAS  Google Scholar 

  32. Kucukhuseyin O, Yilmaz-Aydogan H, Isbir CS, Isbir T (2012) Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease? Mol Biol Rep 39(4):4423–4428

    Article  PubMed  CAS  Google Scholar 

  33. Lu L, Jin PuL, Chen QJ, Wang L, Peng W, Yan X, Zhang Q, Yan Zhang R, Gong PH, Qiu JP, Shen WF (2008) Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients. Clin Chim Acta 396(1–2):33–37

    Article  PubMed  CAS  Google Scholar 

  34. Lu W (2011) Association of RAGE gene polymorphisms with the presence and the severity of coronary artery disease in non-diabetic Han populations. J Soochow Univ Med Sci Ed 21(3):454–458

    Google Scholar 

  35. Peng WH, Lu L, Wang LJ, Yan XX, Chen QJ, Zhang Q, Zhang RY, Shen WF (2009) RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. Arch Med Res 40(5):393–398

    Article  PubMed  CAS  Google Scholar 

  36. Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Groop PH (2003) The functional −374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 52(3):891–894

    Article  PubMed  CAS  Google Scholar 

  37. dos Santos KG, Canani LH, Gross JL, Tschiedel B, Pires Souto KE, Roisenberg I (2005) The −374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol Genet Metab 85(2):149–156

    Article  PubMed  Google Scholar 

  38. Xie G (2010) Association of −374T/A polymorphism of RAGE with coronary heart disease in Chinese Han population. South China J Cardiovasc Dis 16(6):468–470

    CAS  Google Scholar 

  39. Yoon SJ, Park S, Shim CY, Park CM, Ko YG, Choi D, Park HY, Oh B, Kim H, Jang Y, Chung N (2007) Association of RAGE gene polymorphisms with coronary artery disease in the Korean population. Coron Artery Dis 18(1):1–8

    Article  PubMed  Google Scholar 

  40. Zee RY, Romero JR, Gould JL, Ricupero DA, Ridker PM (2006) Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke. Stroke 37(7):1686–1690

    Article  PubMed  CAS  Google Scholar 

  41. Libby P (2006) Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83(2):456S–460S

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xing-biao Qiu.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 120 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, L., Qiu, Xb. Association between the receptor for advanced glycation end products gene polymorphisms and coronary artery disease. Mol Biol Rep 40, 6097–6105 (2013). https://doi.org/10.1007/s11033-013-2721-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-013-2721-1

Keywords

Navigation